Companies /Healthcare

Inovio Pharmaceuticals Inc

NASDAQ: INO Biotechnology
$1.13
▼ $0.02 (−1.74%) today
Markets closed · 3:35am ET

INO Coverage Page 3

10:05am ET
Health and Healthcare

Inovio Pharma Tanks on FDA Clinical Hold

Shares of Inovio Pharmaceuticals slid in Monday’s session on news that the FDA placed a clinical hold on a proposed Inovio Phase 3 clinical program.

INO
Chris Lange